Key result
Insulin resistance links to impaired macrovascular but not microvascular reactivity in hypertensive patients.
Why the study?
Is insulin resistance more closely related to macrovasculature or microvasculature reactivity in patients with hypertension?
Cross-Sectional (n=75)
Is insulin resistance more closely related to macrovasculature or microvasculature reactivity in patients with hypertension?
In hypertensive patients without other cardiovascular risk factors, insulin resistance is associated with impaired macrovascular (FMD) but not microvascular (SRH) reactivity.
Insulin resistance may preferentially impair macrovascular reactivity in hypertension; leaves open causality and clinical relevance.
BACKGROUND: Although insulin resistance (IR) is thought to be related to vascular dysfunction, the difference in the relationship of IR to microvasculature and macrovasculature reactivity has not yet been clarified. The present study was conducted to clarify whether the IR is more closely related to the macrovasculature reactivity (flow-mediated vasodilatation of the brachial artery induced by reactive hyperemia: FMD) or microvasculature reactivity (skin reactive hyperemia as assessed by laser Doppler flowmetry: SRH) in patients with hypertension. METHODS: In 75 consecutive hypertensive patients (61 +/- 11 years of age) without obvious cardiovascular (CV) disease and/or risk factors for CV disease other than hypertension, FMD, SRH, and homeostasis model assessment index of IR (HOMA(IR)) were measured. RESULTS: No significant relationship was observed between FMD with the parameters of SRH. In the univariate linear regression analysis, HOMA(IR) showed a significant correlation with the FMD (R(2) = 0.05, P < 0.05), but not with the parameters of SRH. Multivariate linear regression analysis demonstrated a significant association between HOMA(IR) and FMD, even after adjustments for covariates, including the use of medication for hypertension. (R(2) = 0.32, beta = -0.29, P = 0.02). CONCLUSIONS: The complication of IR in hypertensive patients without obvious CV disease/risk factors may be related to impaired macrovasculature rather than microvasculature reactivity, apart from the influence of antihypertensive medication on the reactivity of the vasculature and insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2010) conducted a cross-sectional in Hypertension (n=75). Insulin resistance (HOMA-IR) was evaluated on Macrovasculature reactivity (FMD) and microvasculature reactivity (SRH) (beta = -0.29, p=0.02). Insulin resistance (HOMA-IR) was significantly associated with impaired macrovasculature reactivity (FMD) (beta = -0.29, P=0.02), but not microvasculature reactivity, in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: